Intranasal Betahistines Could Offer A New Treatment For Vertigo

Vertigo treatment

Though fairly common, vertigo is a frightening illness experienced by many people. Everyone, at one time or another, has felt the crippling effects of a dizzy spell. Walking, standing or moving can be difficult as you feel like your entire world is spinning out of control. Relief is often found only by sitting or lying down and allowing the attack to run its course. For some people, however, the horrors of this affliction are frequent occurrences requiring daily doses of medication.

Chronic Vertigo Treatment

Among the most well-known causes of chronic vertigo is a condition called Meniere’s Disease, an inner ear disorder. In addition to dizziness, this affliction produces other alarming symptoms including tinnitus (ringing in the ears), nausea, balance problems and, in some cases, hearing loss.
For decades, throughout the United States and across the world, the standard Vertigo treatment for dizziness and related symptoms has been a drug called Betahistine Hydrochloride, or simply Betahistine. Physicians and scientists believe inner ear problems like Meniere’s Disease are the result of a pressure build up in the ear cavity. Betahistines are said to be effective because they alleviate and eliminate the accumulation of pressure.

Referred to and sold under brand names including, but not limited to Serc, Veserc, Hiserk, Betaserc and Vergo, Betahistines are typically available through a doctor’s prescription. Patients are often instructed to take the drug orally several times per day. In addition to the frequency with which the drug must be taken, it can, in sensitive individuals, elicit side effects. Side effects can range in severity and may include digestive difficulties, headaches, and allergic reactions.

New Chronic Vertigo Treatment Is Almost Here!

The Hearing Doctors are pleased to announce that a more efficient method of treatment might soon be in the offing. Earlier this year, Auris, a Switzerland-based company dedicated to developing medications and therapies for ear, nose and throat disorders announced it is in the developmental stages of creating a spray form of Betahistine, known as Intranasal Betahistine. Should this form of treatment one day be approved, those afflicted with Meniere’s Disease and other illnesses causing similar symptoms would be able to treat their condition by spraying a liquid solution into their nasal cavity and not have to be reliant on oral medications which could cause other untoward symptoms.

More than two years ago, Otifex, an Australian pharmaceutical company studying ways to treat and cure Otitis Media, an ear infection which is often found in children and could lead to hearing loss, conducted a clinical trial of Betahistine nasal spray preparations. A number of healthy adult volunteer subjects were administered the drug at various dosage levels. Otifex’s study concluded the drug had few deleterious effects and seemed to be efficient.

The potential development of a Betahistine nasal spray is said to be a significant breakthrough for the many millions, including the more than half million people in the United States, who suffer from vertigo worldwide. Auris has named their Intranasal Betahistine preparation AM-125 and, later this year, plan to conduct a clinical trial of their own designed to determine how efficient and safe the drug is.

Contact Us Right Away!

For more information, please contact The Hearing Doctors.

©2018 Hearing Aids, All Rights Reserved. MyCity Social

Log in with your credentials

Forgot your details?